| ACEi | angiotensin-converting enzyme inhibitor |
| anti-PLA2R | anti-phospholipase A2 receptor |
| ARB | angiotensin receptor blocker |
| CI | confidence interval |
| CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
| CNI | calcineurin inhibitor |
| CR | complete remission |
| eGFR | estimated glomerular filtration rate |
| IQR | interquartile range |
| KDIGO | Kidney Disease: Improving Global Outcomes |
| OR | odds ratio |
| PMN | primary membranous nephropathy |
| PR | partial remission |
| RTX | rituximab |
| SGLT2i | sodium-glucose cotransporter-2 inhibitor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.